Cargando…

HDAC Inhibitors Enhance Efficacy of the Oncolytic Adenoviruses Ad∆∆ and Ad-3∆-A20T in Pancreatic and Triple-Negative Breast Cancer Models

The prognosis for triple-negative breast cancer (TNBC) and pancreatic ductal adenocarcinoma (PDAC) is dismal. TNBC and PDAC are highly aggressive cancers with few treatment options and a potential for rapid resistance to standard-of-care chemotherapeutics. Oncolytic adenoviruses (OAds) represent a p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rodríguez, María Del Carmen Rodríguez, Rodríguez, Inés García, Nattress, Callum, Qureshi, Ahad, Halldén, Gunnel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9143155/ https://www.ncbi.nlm.nih.gov/pubmed/35632748 http://dx.doi.org/10.3390/v14051006

Ejemplares similares

Targeting Triple Negative Breast Cancer With Oncolytic Adenoviruses
por: Green-Tripp, Gabriela, et al.
Publicado: (2022)

Complexing the Oncolytic Adenoviruses Ad∆∆ and Ad-3∆-A20T with Cationic Nanoparticles Enhances Viral Infection and Spread in Prostate and Pancreatic Cancer Models
por: Man, Yang Kee Stella, et al.
Publicado: (2022)

Sensitisation to mitoxantrone-induced apoptosis by the oncolytic adenovirus Ad∆∆ through Bcl-2-dependent attenuation of autophagy
por: Aguirre-Hernández, Carmen, et al.
Publicado: (2018)

Oncolytic adenovirus-mediated therapy for prostate cancer
por: Sweeney, Katrina, et al.
Publicado: (2016)

Designer Oncolytic Adenovirus: Coming of Age
por: Baker, Alexander T., et al.
Publicado: (2018)

The E1B19K-deleted oncolytic adenovirus mutant AdΔ19K sensitizes pancreatic cancer cells to drug-induced DNA-damage by down-regulating Claspin and Mre11
por: Pantelidou, Constantia, et al.
Publicado: (2016)

Oncolytic adenovirus Ad657 for systemic virotherapy against prostate cancer
por: Nguyen, Tien V, et al.
Publicado: (2018)

Superior infectivity of the fiber chimeric oncolytic adenoviruses Ad5/35 and Ad5/3 over Ad5-delta-24-RGD in primary glioma cultures
por: Stepanenko, Aleksei A., et al.
Publicado: (2021)

Rodents Versus Pig Model for Assessing the Performance of Serotype Chimeric Ad5/3 Oncolytic Adenoviruses
por: Koodie, Lisa, et al.
Publicado: (2019)

A new insight into aggregation of oncolytic adenovirus Ad5-delta-24-RGD during CsCl gradient ultracentrifugation
por: Stepanenko, Aleksei A., et al.
Publicado: (2021)

Systemic delivery and SPECT/CT in vivo imaging of (125)I-labelled oncolytic adenoviral mutants in models of pancreatic cancer
por: Stella Man, Y. K., et al.
Publicado: (2019)

Ad 2.0: a novel recombineering platform for high-throughput generation of tailored adenoviruses
por: Mück-Häusl, Martin, et al.
Publicado: (2015)

Low-dose paclitaxel synergizes with oncolytic adenoviruses via mitotic slippage and apoptosis in ovarian cancer
por: Ingemarsdotter, C K, et al.
Publicado: (2010)

Doxorubicin Conjugation to Reovirus Improves Oncolytic Efficacy in Triple-Negative Breast Cancer
por: Berry, Jameson T.L., et al.
Publicado: (2020)

The Structural Basis for the Integrity of Adenovirus Ad3 Dodecahedron
por: Szolajska, Ewa, et al.
Publicado: (2012)

Oncolytic Adenoviruses in Gastrointestinal Cancers
por: Yokoda, Raquel T., et al.
Publicado: (2018)

Oncolytic Adenoviruses in Cancer Treatment
por: Alemany, Ramon
Publicado: (2014)

Oncolytic Adenovirus in Cancer Immunotherapy
por: Peter, Malin, et al.
Publicado: (2020)

Oncolytic Adenoviruses for Cancer Therapy
por: Tripodi, Lorella, et al.
Publicado: (2021)

Concepts in Oncolytic Adenovirus Therapy
por: Mantwill, Klaus, et al.
Publicado: (2021)

A Renaissance for Oncolytic Adenoviruses?
por: Blanchette, Paola, et al.
Publicado: (2023)

Oncolytic adenoviruses and the treatment of pancreatic cancer: a review of clinical trials
por: Taylor, Isobel P., et al.
Publicado: (2023)

Transient Chimeric Ad5/37 Fiber Enhances NK-92 Carrier Cell-Mediated Delivery of Oncolytic Adenovirus Type 5 to Tumor Cells
por: Gao, Jian, et al.
Publicado: (2020)

A role for macrophages under cytokine control in mediating resistance to ADI-PEG20 (pegargiminase) in ASS1-deficient mesothelioma
por: Phillips, Melissa M., et al.
Publicado: (2023)

Correction: A role for macrophages under cytokine control in mediating resistance to ADI-PEG20 (pegargiminase) in ASS1-deficient mesothelioma
por: Phillips, Melissa M., et al.
Publicado: (2023)

Eradication of metastatic melanoma through cooperative expression of RNA-based HDAC1 inhibitor and p73 by oncolytic adenovirus
por: Schipper, Holger, et al.
Publicado: (2014)

Oncolytic viruses for triple negative breast cancer and beyond
por: Jin, Shengye, et al.
Publicado: (2021)

Synergistic effect of bladder cancer-specific oncolytic adenovirus in combination with chemotherapy
por: Li, Shuwen, et al.
Publicado: (2017)

A Tumor-Targeted Replicating Oncolytic Adenovirus Ad-TD-nsIL12 as a Promising Therapeutic Agent for Human Esophageal Squamous Cell Carcinoma
por: Zhang, Zifang, et al.
Publicado: (2020)

Clinical-grade Oncolytic Adenovirus Purification using Polysorbate 20 as an Alternative for Cell Lysis
por: Moleirinho, Mafalda G., et al.
Publicado: (2018)

Different memory T cell phenotypes are elicited by Ad5 and rare adenoviruses
por: Penaloza, P, et al.
Publicado: (2012)

GAMER-Ad: a novel and rapid method for generating recombinant adenoviruses
por: Hamdan, Firas, et al.
Publicado: (2021)

Triple-serotype chimeric oncolytic adenovirus exerts multiple synergistic mechanisms against solid tumors
por: Su, Yinghan, et al.
Publicado: (2022)

Patient-derived pancreatic tumour organoids identify therapeutic responses to oncolytic adenoviruses
por: Raimondi, Giulia, et al.
Publicado: (2020)

Stability of Chimpanzee Adenovirus Vectored Vaccines (ChAdOx1 and ChAdOx2) in Liquid and Lyophilised Formulations
por: Berg, Adam, et al.
Publicado: (2021)

Lyophilization to enable distribution of ChAdOx1 and ChAdOx2 adenovirus-vectored vaccines without refrigeration
por: Zhang, Cheng, et al.
Publicado: (2023)

Increasing the Efficacy of Oncolytic Adenovirus Vectors
por: Toth, Karoly, et al.
Publicado: (2010)

Oncolytic Adenovirus: Prospects for Cancer Immunotherapy
por: Zhao, Yaqi, et al.
Publicado: (2021)

Oncolytic adenovirus for treatment of malignant ascites
por: Hemminki, Akseli, et al.
Publicado: (2022)

Adenovirus as a Vector and Oncolytic Virus
por: Matsunaga, Wataru, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_6odqdgec3340e9219mdena67i7